Toki-shakuyaku-san treatment ameliorated disease severity in DSS induced colitis.
It has down-regulated the ER stress and apoptotic signaling during colitis.
It has alleviated the production of inflammatory cytokines.
It can be used as a promising therapeutic measure for IBD.